{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:20:53Z","timestamp":1792682453777,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ijbiomac.2021.05.050","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T04:43:50Z","timestamp":1620449030000},"page":"1096-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Feasibility of chitosan-based nanoparticles approach for intranasal immunisation of live attenuated Japanese encephalitis vaccine"],"prefix":"10.1016","volume":"183","author":[{"given":"Ekachai","family":"Dumkliang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boonnada","family":"Pamornpathomkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasopchai","family":"Patrojanasophon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanasait","family":"Ngawhirunpat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theerasak","family":"Rojanarata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutee","family":"Yoksan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praneet","family":"Opanasopit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2019.197770","article-title":"Flavivirus infection-a review of immunopathogenesis, immunological response, and immunodiagnosis","volume":"274","author":"Chong","year":"2019","journal-title":"Virus Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.05.050_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1285472","article-title":"Japanese encephalitis vaccines: immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease","volume":"13","author":"Hegde","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.05.050_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6802a1","article-title":"Japanese encephalitis vaccine: recommendations of the advisory committee on immunization practices","volume":"68","author":"Hills","year":"2019","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijid.2020.10.061","article-title":"Epidemiology of Japanese encephalitis in the Philippines prior to routine immunization","volume":"102","author":"Lopez","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103678","article-title":"Japanese encephalitis virus: associated immune response and recent progress in vaccine development","volume":"136","author":"Kumar","year":"2019","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.05.050_bb0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","article-title":"Current prospects and future challenges for nasal vaccine delivery","volume":"13","author":"Yusuf","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"issue":"14","key":"10.1016\/j.ijbiomac.2021.05.050_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145016","article-title":"New opportunity to formulate intranasal vaccines and drug delivery systems based on chitosan","volume":"21","author":"Popescu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10832","article-title":"Vector-free transmission and persistence of Japanese encephalitis virus in pigs","volume":"7","author":"Ricklin","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.05.050_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7883\/yoken.JJID.2009.37","article-title":"Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus","volume":"62","author":"Harakuni","year":"2009","journal-title":"Jpn. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.05.050_bb0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.micinf.2011.09.004","article-title":"Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice","volume":"14","author":"Tafuku","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijbiomac.2017.10.101","article-title":"Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases","volume":"110","author":"Singh","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.05.050_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10717544.2014.908427","article-title":"Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response","volume":"23","author":"Pawar","year":"2016","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.05.050_bb0065","article-title":"Chitosan and its derivatives for application in mucoadhesive drug delivery systems","volume":"10","author":"TM","year":"2018","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.carbpol.2018.08.119","article-title":"6-Maleimidohexanoic acid-grafted chitosan: a new generation mucoadhesive polymer","volume":"202","author":"Sahatsapan","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"1662\u20139795","key":"10.1016\/j.ijbiomac.2021.05.050_bb0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4028\/www.scientific.net\/KEM.859.214","article-title":"Preparation and evaluation of 6-maleimidohexanoic acid grafted chitosan nanoparticles as a novel carrier for intranasal protein delivery","volume":"859","author":"Dumkliang","year":"2020","journal-title":"Key Eng. Mater."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0080","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.biomaterials.2016.08.035","article-title":"Biomineralized vaccine nanohybrid for needle-free intranasal immunization","volume":"106","author":"Wang","year":"2016","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.05.050_bb0085","first-page":"586","article-title":"Ex vivo evaluation in porcine nasal mucosa of PLGA exaggerated mucoadhesive substances, Al(OH)3 and chitosan, as nasal vaccine carrier","volume":"11","author":"Tunsirikongkon","year":"2011","journal-title":"J. Pharm. Sci. Technol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.05.050_bb0090","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1211\/0022357011778197","article-title":"Interpretation of mucoadhesive properties of polymer gel preparations using a tensile strength method","volume":"53","author":"Hagerstrom","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111279","article-title":"Catechol-modified chitosan\/hyaluronic acid nanoparticles as a new avenue for local delivery of doxorubicin to oral cancer cells","volume":"196","author":"Pornpitchanarong","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejpb.2017.10.008","article-title":"In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin","volume":"122","author":"Mura","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.05.050_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/1061186031000093254","article-title":"Uptake of ovalbumin-conjugated starch microparticles by pig respiratory nasal mucosa in vitro","volume":"11","author":"Osth","year":"2003","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.05.050_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1046-2023(03)00139-7","article-title":"Mucosal immunization with DNA vaccines","volume":"31","author":"Hobson","year":"2003","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.05.050_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/338015","article-title":"Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein","volume":"185","author":"Kaur","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.05.050_bb0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12272-017-0985-z","article-title":"Comparison of the adjuvanticity of two adjuvant formulations containing de-O-acylated lipooligosaccharide on Japanese encephalitis vaccine in mice","volume":"41","author":"Ko","year":"2018","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.05.050_bb0125","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/21645515.2017.1414763","article-title":"Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children","volume":"14","author":"Chanthavanich","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0130","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ijbiomac.2016.06.015","article-title":"Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery","volume":"91","author":"Gao","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.carbpol.2018.02.073","article-title":"Chitosan stabilized nasal emulsion delivery system for effective humoral and cellular response against recombinant tetravalent dengue antigen","volume":"190","author":"Vemireddy","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.05.050_bb0140","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1021\/acsabm.9b00597","article-title":"Cationic pH responsive polycaprolactone nanoparticles as intranasal antigen delivery system for potent humoral and cellular immunity against recombinant tetravalent dengue antigen","volume":"2","author":"Vemireddy","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2019.02.026","article-title":"How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods","volume":"561","author":"Salade","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.05.050_bb0150","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/j.xphs.2019.05.006","article-title":"Synthesis and evaluation of boronated chitosan as a mucoadhesive polymer for intravesical drug delivery","volume":"108","author":"Kolawole","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.05.050_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080367","article-title":"Improved in vitro model for intranasal mucosal drug delivery: primary olfactory and respiratory epithelial cells compared with the permanent nasal cell line RPMI 2650","volume":"11","author":"Ladel","year":"2019","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.05.050_bb0160","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/molecules14093754","article-title":"Nasal delivery of high molecular weight drugs","volume":"14","author":"Ozsoy","year":"2009","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.05.050_bb0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/viro.1999.9695","article-title":"Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis","volume":"257","author":"Guirakhoo","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2017.00569","article-title":"Simultaneous subcutaneous and intranasal administration of a CAF01-adjuvanted chlamydia vaccine elicits elevated IgA and protective Th1\/Th17 responses in the genital tract","volume":"8","author":"Wern","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bmb\/62.1.15","article-title":"Immunology of vaccination","volume":"62","author":"Beverley","year":"2002","journal-title":"Br. Med. Bull."},{"issue":"23","key":"10.1016\/j.ijbiomac.2021.05.050_bb0180","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.vaccine.2009.03.034","article-title":"Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy","volume":"27","author":"Demento","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.05.050_bb0185","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/eji.201243152","article-title":"Cytolytic effector pathways and IFN-gamma help protect against Japanese encephalitis","volume":"43","author":"Larena","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0190","series-title":"NPJ Vaccines","first-page":"5","article-title":"Gamma-interferon exerts a critical early restriction on replication and dissemination of yellow fever virus vaccine strain 17D-204","volume":"3","author":"Lam","year":"2018"},{"key":"10.1016\/j.ijbiomac.2021.05.050_bb0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.micro.55.1.255","article-title":"Viruses and interferons","volume":"55","author":"Sen","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.05.050_bb0200","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1086\/381768","article-title":"Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae","volume":"189","author":"Kumar","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.05.050_bb0205","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrneurol.2018.30","article-title":"Japanese encephalitis - the prospects for new treatments","volume":"14","author":"Turtle","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.05.050_bb0210","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/jmv.24893","article-title":"Detection of long term cellular immune response to Japanese encephalitis vaccination using IFN-gamma ELIspot assay","volume":"89","author":"Zia","year":"2017","journal-title":"J. Med. Virol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021010199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021010199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:03:50Z","timestamp":1758877430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813021010199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":42,"alternative-id":["S0141813021010199"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.05.050","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of chitosan-based nanoparticles approach for intranasal immunisation of live attenuated Japanese encephalitis vaccine","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.05.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}